KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to 0.32%.

  • Biolife Solutions' EBIT Margin rose 16400.0% to 0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.03%, marking a year-over-year decrease of 317800.0%. This contributed to the annual value of 8.67% for FY2024, which is 222300.0% up from last year.
  • As of Q3 2025, Biolife Solutions' EBIT Margin stood at 0.32%, which was up 16400.0% from 65.47% recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' EBIT Margin registered a high of 0.32% during Q3 2025, and its lowest value of 218.96% during Q4 2022.
  • Moreover, its 5-year median value for EBIT Margin was 28.81% (2022), whereas its average is 52.12%.
  • As far as peak fluctuations go, Biolife Solutions' EBIT Margin crashed by -1742900bps in 2022, and later soared by 1747600bps in 2024.
  • Quarter analysis of 5 years shows Biolife Solutions' EBIT Margin stood at 49.5% in 2021, then plummeted by -342bps to 218.96% in 2022, then increased by 16bps to 184.05% in 2023, then surged by 95bps to 9.29% in 2024, then skyrocketed by 97bps to 0.32% in 2025.
  • Its EBIT Margin was 0.32% in Q3 2025, compared to 65.47% in Q2 2025 and 5.09% in Q1 2025.